Interleukin-6 is antiproliferative to a mouse hybridoma cell line and promotive for its antibody productivity
- 1 January 1992
- journal article
- research article
- Published by Springer Nature in Cytotechnology
- Vol. 10 (1) , 15-23
- https://doi.org/10.1007/bf00376096
Abstract
Monoclonal antibody production by hybridoma cells at moderately slowed growth states would be favorable for commercial scale production since cells can devote their resources to performing the differentiated function, immunoglobulin production. We found that a purified recombinant human interleukin-6, which had been reported to support or stimulate proliferation of B cell hybridoma/plasmacytoma cells, suppressed growth of a hybridoma cell line in serum-free medium. In the presence of the interleukin, the growth-suppressed cells were viable for remarkably long periods in batch culture, and after removal of the interleukin from the culture medium, they started to proliferate at their normal growth rate. As the concentration of the interleukin increased in the culture, the growth rate decreased and the specific antibody productivity (antibody production rate per cell) increased to 5-fold of control at 10 U ml−1 (2 ng ml−1) of the interleukin.Keywords
This publication has 24 references indexed in Scilit:
- Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.The Journal of Experimental Medicine, 1990
- Recombinant human interleukin 6 (B‐cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1)FEBS Letters, 1988
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes.The Journal of Experimental Medicine, 1988
- cDNA cloning of murine interleukin-HP1: homology with human interleukin 6European Journal of Immunology, 1988
- The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.The Journal of Experimental Medicine, 1988
- Recombinant human B cell stimulatory factor 2 (BSF‐2/IFN‐β2) regulates β‐fibrinogen and albumin mRNA levels in Fao‐9 cellsFEBS Letters, 1987
- Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1987
- Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.The Journal of Experimental Medicine, 1987
- A Macrophage-Derived Factor Required by Plasmacytomas for Survival and Proliferation in VitroScience, 1986